• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SCHEDULE 13G filed by Inflection Point Acquisition Corp. IV

    3/24/26 4:37:56 PM ET
    $BACQ
    Get the next $BACQ alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    Merlin, Inc.

    (Name of Issuer)


    Common Stock, par value $0.0001 per share

    (Title of Class of Securities)




    590106100

    (CUSIP Number)
    03/16/2026

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox not checked   Rule 13d-1(b)
    Checkbox checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)




    schemaVersion:


    SCHEDULE 13G

    CUSIP Number(s):
    590106100


    1Names of Reporting Persons

    SnowPoint Ventures, LP
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    1,980,701.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    1,980,701.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,980,701.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    2.3 %
    12Type of Reporting Person (See Instructions)

    PN


    SCHEDULE 13G

    CUSIP Number(s):
    590106100


    1Names of Reporting Persons

    SnowPoint Growth I.II, LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    6,272,239.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    6,272,239.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    6,272,239.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    7.3 %
    12Type of Reporting Person (See Instructions)

    OO


    SCHEDULE 13G

    CUSIP Number(s):
    590106100


    1Names of Reporting Persons

    SnowPoint Ventures GP, LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    8,252,940.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    8,252,940.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    8,252,940.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    9.6 %
    12Type of Reporting Person (See Instructions)

    OO


    SCHEDULE 13G

    CUSIP Number(s):
    590106100


    1Names of Reporting Persons

    Alexander Creasey
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    8,252,940.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    8,252,940.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    8,252,940.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    9.6 %
    12Type of Reporting Person (See Instructions)

    IN


    SCHEDULE 13G

    CUSIP Number(s):
    590106100


    1Names of Reporting Persons

    Douglas Philippone
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    8,252,940.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    8,252,940.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    8,252,940.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    9.6 %
    12Type of Reporting Person (See Instructions)

    IN


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    Merlin, Inc.
    (b)Address of issuer's principal executive offices:

    129 South Street, Boston, MA, 02111.
    Item 2. 
    (a)Name of person filing:

    The names of the persons filing this report (collectively, the "Reporting Persons") are: SnowPoint Ventures, LP ("SP Ventures") SnowPoint Growth I.II, LLC ("SP Growth I.II") SnowPoint Ventures GP, LLC ("SP Ventures GP") Alexander Creasey ("Creasey") Douglas Philippone ("Philippone") The Reporting Persons expressly disclaim status as a "group" for purposes of this Schedule 13G.
    (b)Address or principal business office or, if none, residence:

    595 Pacific Ave., 4th Floor San Francisco, CA 94133
    (c)Citizenship:

    SP Ventures Delaware SP Growth I.II Delaware SP Ventures GP Delaware Creasey United States Philippone United States
    (d)Title of class of securities:

    Common Stock, par value $0.0001 per share
    (e)CUSIP Number(s):

    590106100
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox not checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    Row 9 of each Reporting Person's cover page to this Schedule 13G sets forth the aggregate number of shares of common stock of the Issuer beneficially owned by such Reporting Person and is incorporated by reference. The Reporting Persons' ownership of the Issuer's securities consists of (i) 1,593,002 shares of common stock, 190,914 shares of Series A preferred stock ("Preferred Stock") immediately convertible into common stock on a one-for-one basis, and warrants (the "Warrants") immediately exercisable for up to 196,785 shares of common stock held directly by SP Ventures; and (ii) 5,044,528 shares of common stock, 604,560 shares of Preferred Stock immediately convertible into common stock on a one-for-one basis, and Warrants immediately exercisable for up to 623,151 shares of common stock held directly by SP Growth I.II. SP Ventures GP is the general partner of SP Ventures and the manager of SP Growth I.II and Messrs. Creasey and Philippone are the managers of SP Ventures GP. Each of SP Ventures GP, and Messrs. Creasey and Philippone shares voting and investment authority over the shares held by each of SP Ventures and SP Growth I.II.
    (b)Percent of class:

    Row 11 of each Reporting Person's cover page to this Schedule 13G sets forth the percentages of the shares of common stock of the Issuer beneficially owned by such Reporting Person and is incorporated by reference. The percentage set forth in each row 11 is based upon 84,262,893 shares of common stock outstanding as of March 16, 2026 as reported in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission (the "SEC") on March 20, 2026, and giving effect to the conversion of Preferred Stock and exercise of Warrants held by the Reporting Persons, to the extent convertible and/or exercisable within 60 days hereof, as referenced herein.
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    Row 5 of each Reporting Person's cover page to this Schedule 13G sets forth the sole power to vote or to direct the vote of securities of the Issuer beneficially owned by such Reporting Person and is incorporated by reference.

     (ii) Shared power to vote or to direct the vote:

    Row 6 of each Reporting Person's cover page to this Schedule 13G sets forth the shared power to vote or to direct the vote of securities of the Issuer beneficially owned by such Reporting Person and is incorporated by reference.

     (iii) Sole power to dispose or to direct the disposition of:

    Row 7 of each Reporting Person's cover page to this Schedule 13G sets forth the sole power to dispose or to direct the disposition of securities of the Issuer beneficially owned by such Reporting Person and is incorporated by reference.

     (iv) Shared power to dispose or to direct the disposition of:

    Row 8 of each Reporting Person's cover page to this Schedule 13G sets forth the shared power to dispose or to direct the disposition of securities of the Issuer beneficially owned by such Reporting Person and is incorporated by reference.

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Not Applicable
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    Not Applicable
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    SnowPoint Ventures, LP
     
    Signature:/s/ Alexander Creasey
    Name/Title:By SnowPoint Ventures GP, LLC, Its General Partner, By Alexander Creasey, Manager
    Date:03/23/2026
     
    SnowPoint Growth I.II, LLC
     
    Signature:/s/ Alexander Creasey
    Name/Title:By SnowPoint Ventures GP, LLC, Its Manager, By Alexander Creasey, Manager
    Date:03/23/2026
     
    SnowPoint Ventures GP, LLC
     
    Signature:/s/ Alexander Creasey
    Name/Title:By Alexander Creasey, Manager
    Date:03/23/2026
     
    Alexander Creasey
     
    Signature:/s/ Alexander Creasey
    Name/Title:Alexander Creasey
    Date:03/23/2026
     
    Douglas Philippone
     
    Signature:/s/ Douglas Philippone
    Name/Title:Douglas Philippone
    Date:03/23/2026
    Exhibit Information

    Exhibit 99.1 Joint Filing Agreement

    Get the next $BACQ alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BACQ

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BACQ
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Merlin Successfully Completes Preliminary Design Review for C-130J Autonomy Program with USSOCOM

    PDR approval marks major technical progress toward production-ready reduced aircrew capability for C-130J aircraft Merlin Labs, Inc. (Merlin), an aerospace and defense technology company building the operating system of record for autonomous flight, today announced the successful completion of the Preliminary Design Review (PDR) for its C-130J autonomy program with the U.S. Special Operations Command (USSOCOM). Completion of the PDR is a major milestone in the program's technical maturation and clears the way for an immediate transition into the Critical Design stage, an essential step in validating the maturation of the system's design. Upon completion of the PDR, Merlin's preliminary in

    3/5/26 9:00:00 AM ET
    $BACQ

    Merlin Labs to Host Investor & Analyst Webinar on March 3, 2026

    Merlin Labs, Inc. (Merlin), an aerospace and defense technology company building the operating system of record for autonomous flight, will host an Investor & Analyst Webinar on March 3, 2026 at 1:00pm ET. The webinar will include a formal presentation and Q&A session with the management team of Merlin. Merlin previously announced that it had entered into a Business Combination Agreement with Inflection Point Acquisition Corp. IV (NASDAQ:BACQ) on August 13, 2025, pursuant to which it intends to become a publicly traded company through a business combination (the "Transaction"). As previously disclosed, the Transaction is expected to accelerate the delivery of new capabilities to custome

    2/20/26 9:00:00 AM ET
    $BACQ

    Merlin Expands Executive Team Ahead of Public Listing

    Leslie Ravestein joins as Chief Legal Officer, David Lasater as Chief People Officer, and Pablo Gonzalez as Senior Vice President of Engineering Merlin Labs, Inc. ("Merlin"), a leading developer of assured, autonomous flight technology for defense customers, today announced key additions to its executive leadership team to optimize the organization in advance of its public listing via a Business Combination with Inflection Point Acquisition Corp. IV (NASDAQ:BACQ). The hires include two C-Suite additions, Leslie Ravestein as Chief Legal Officer and David Lasater as Chief People Officer, to strengthen corporate governance, drive operational excellence, and elevate talent strategy. Merlin al

    11/19/25 9:00:00 AM ET
    $AKAM
    $BACQ
    $DELL
    Real Estate
    Computer Manufacturing
    Technology
    Computer Software: Prepackaged Software

    $BACQ
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Inflection Point Acquisition Corp. IV

    4 - Merlin, Inc. (0002028707) (Issuer)

    3/18/26 5:06:27 PM ET
    $BACQ

    SEC Form 3 filed by Inflection Point Acquisition Corp. IV

    3 - Merlin, Inc. (0002028707) (Issuer)

    3/18/26 5:00:15 PM ET
    $BACQ

    SEC Form 3 filed by Inflection Point Acquisition Corp. IV

    3 - Merlin, Inc. (0002028707) (Issuer)

    3/18/26 5:02:34 PM ET
    $BACQ

    $BACQ
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Inflection Point Acquisition Corp. IV

    SCHEDULE 13G - Merlin, Inc. (0002028707) (Subject)

    3/24/26 4:37:56 PM ET
    $BACQ

    SEC Form SCHEDULE 13G filed by Inflection Point Acquisition Corp. IV

    SCHEDULE 13G - Merlin, Inc. (0002028707) (Subject)

    3/23/26 4:30:14 PM ET
    $BACQ

    Inflection Point Acquisition Corp. IV filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Completion of Acquisition or Disposition of Assets, Change in Shell Company Status, Financial Statements and Exhibits, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Changes in Registrant's Certifying Accountant, Changes in Control of Registrant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events

    8-K - Merlin, Inc. (0002028707) (Filer)

    3/20/26 4:01:27 PM ET
    $BACQ

    $BACQ
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Goldman Sachs Group Inc bought $46,773 worth of shares (4,328 units at $10.81) and sold $52,707 worth of shares (4,872 units at $10.82) (SEC Form 4)

    4 - INFLECTION POINT ACQUISITION CORP. IV (0002028707) (Issuer)

    2/26/26 6:01:08 PM ET
    $BACQ

    $BACQ
    Leadership Updates

    Live Leadership Updates

    View All

    Merlin Expands Executive Team Ahead of Public Listing

    Leslie Ravestein joins as Chief Legal Officer, David Lasater as Chief People Officer, and Pablo Gonzalez as Senior Vice President of Engineering Merlin Labs, Inc. ("Merlin"), a leading developer of assured, autonomous flight technology for defense customers, today announced key additions to its executive leadership team to optimize the organization in advance of its public listing via a Business Combination with Inflection Point Acquisition Corp. IV (NASDAQ:BACQ). The hires include two C-Suite additions, Leslie Ravestein as Chief Legal Officer and David Lasater as Chief People Officer, to strengthen corporate governance, drive operational excellence, and elevate talent strategy. Merlin al

    11/19/25 9:00:00 AM ET
    $AKAM
    $BACQ
    $DELL
    Real Estate
    Computer Manufacturing
    Technology
    Computer Software: Prepackaged Software

    Merlin Appoints Ryan Carrithers as Chief Financial Officer, Increasing Public Market Readiness

    Carrithers brings to Merlin a unique blend of technical expertise, capital markets experience, and operational rigor, backed by a proven record in scaling innovative automation and aerospace companies Merlin Labs, Inc., a leading developer of assured, autonomous flight technology for defense customers, today appointed Ryan Carrithers as its new Chief Financial Officer. Carrithers joins Merlin at a pivotal moment as the company prepares to go public in a Business Combination with Inflection Point Acquisition Corp. IV (NASDAQ:BACQ). In this role, he will oversee all of Merlin's financial operations and strategy, investor relations, M&A or strategic partnerships that support its autonomy road

    11/4/25 9:00:00 AM ET
    $ASTR
    $BACQ
    $DNA
    Transportation Services
    Consumer Discretionary
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care